Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039238419> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3039238419 abstract "espanolIntroduccion y objetivos El volumen metabolico tumoral (VMT) es un indicador de pronostico prometedor en el linfoma B difuso de celulas grandes (LBDCG). El objetivo del presente estudio es evaluar los diferentes metodos para el calculo del VMT basal con la tomografia por emision de positrones/tomografia computarizada con 18F-fluorodesoxiglucosa (18F-FDG PET/TC) en pacientes con LBDCG, relacionando cada uno de los volumenes medidos con la supervivencia libre de progresion (SLP) y la supervivencia global (SG). Metodologia Se trata de un estudio de cohortes retrospectivo analitico, en el que se incluyeron 34 pacientes sometidos a un 18F-FDG PET/TC basal previo al tratamiento. Comparamos tres umbrales SUV 2,5, SUV 40% del SUV maximo y SUV medio hepatico (PERCIST), para el calculo de los biomarcadores VMT y glucolisis total de la lesion (TLG) relacionandolos con la SLP y SG. El mejor modelo predictivo se selecciono en funcion del valor de criterio de informacion de Akaike (AIC) despues de realizar una regresion de riesgos proporcionales de Cox. Resultados Con relacion a la SLP, muestran diferencias estadisticamente significativas: VMT 2,5, TLG 2,5, VMT 40%, TLG 40%, VMT y TLG calculados con el umbral PERCIST. Entre estos, el que tiene un AIC menor es VMT 2,5, por lo que se considera el mejor parametro para predecir la SLP. Con respecto a la SG, muestra diferencias estadisticamente significativas: VMT 2,5, VMT y TLG calculados con el umbral PERCIST. Entre estos tres, el que tiene un AIC menor es VMT 2,5, por lo que se considera el mejor parametro para predecir la SG. Ademas, un mayor valor de VMT y TLG, se asocia a peor SLP y SG Conclusion El VMT calculado con el umbral SUV 2,5 parece ser el mejor parametro para predecir la SLP y SG en los pacientes diagnosticados con LBDCG con el 18F-FDG PET/TC. EnglishIntroduction and objectives Metabolic tumor volume (MTV) is a promising indicator of prognosis in diffuse large B-cell lymphoma (DLBCL). The aim of the present study is to evaluate the different methods for the calculation of the basal metabolic tumor volume with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in the patients with DLBCL, relating each one of the volumes measured with progression-free survival (PFS) and overall survival (OS). Methodology This is a retrospective analytical cohort study, in which 34 patients underwent to 18F-FDG PET/CT baseline prior to treatment. We compared three SUV thresholds 2.5, SUV 40% of the maximum SUV and SUV mean hepatic uptake (PERCIST) for the calculation of MTV and total lesion glycolysis (TLG) biomarkers, relating them to the PFS and OS. The best predictive model was selected based on the Akaike‘s information criterion (AIC) after performing a Cox proportional hazards regression. Results In relation to the PFS, they show statistically significant differences: MTV 2.5, TLG 2.5, MTV 40, TLG 40, MTV and TLG calculated with the PERCIST threshold. Among these, the one that has a lower AIC is MTV 2.5, so it is considered the best parameter to predict the PFS. With respect to OS, it shows statistically significant differences: MTV 2.5, VMT and TLG calculated with the PERCIST threshold. Among these three, the one with the lowest AIC is MTV 2.5, which is why it is considered the best parameter to predict OS. In addition, a higher value of MTV and total tumor glycolysis (TLG), is associated with worse PFS and OS Conclusion The MTV calculated with the threshold SUV 2.5 seems to be the best parameter to predict PFS and OS in patients diagnosed with DLBCL with 18F-FDG PET/CT." @default.
- W3039238419 created "2020-07-10" @default.
- W3039238419 creator A5007411772 @default.
- W3039238419 creator A5035926939 @default.
- W3039238419 creator A5058184435 @default.
- W3039238419 creator A5061783632 @default.
- W3039238419 creator A5062046770 @default.
- W3039238419 creator A5066391845 @default.
- W3039238419 date "2020-11-01" @default.
- W3039238419 modified "2023-10-01" @default.
- W3039238419 title "Evaluación del valor pronóstico de los diferentes métodos de cálculo del volumen metabólico tumoral con 18F-FDG PET/TC, en pacientes con linfoma B difuso de células grandes" @default.
- W3039238419 cites W1507619039 @default.
- W3039238419 cites W1990157637 @default.
- W3039238419 cites W2066056530 @default.
- W3039238419 cites W2077941010 @default.
- W3039238419 cites W2090149541 @default.
- W3039238419 cites W2095272243 @default.
- W3039238419 cites W2133201432 @default.
- W3039238419 cites W2136060045 @default.
- W3039238419 cites W2182248042 @default.
- W3039238419 cites W2206977664 @default.
- W3039238419 cites W2275941472 @default.
- W3039238419 cites W2503562113 @default.
- W3039238419 cites W2522571310 @default.
- W3039238419 cites W2749123167 @default.
- W3039238419 cites W2782920912 @default.
- W3039238419 cites W2784752532 @default.
- W3039238419 cites W2789910812 @default.
- W3039238419 cites W2798083690 @default.
- W3039238419 cites W2888961273 @default.
- W3039238419 cites W2898770489 @default.
- W3039238419 cites W2900410493 @default.
- W3039238419 cites W2921072067 @default.
- W3039238419 cites W2986111828 @default.
- W3039238419 cites W2992702651 @default.
- W3039238419 cites W3025318838 @default.
- W3039238419 doi "https://doi.org/10.1016/j.remn.2020.06.007" @default.
- W3039238419 hasPublicationYear "2020" @default.
- W3039238419 type Work @default.
- W3039238419 sameAs 3039238419 @default.
- W3039238419 citedByCount "0" @default.
- W3039238419 crossrefType "journal-article" @default.
- W3039238419 hasAuthorship W3039238419A5007411772 @default.
- W3039238419 hasAuthorship W3039238419A5035926939 @default.
- W3039238419 hasAuthorship W3039238419A5058184435 @default.
- W3039238419 hasAuthorship W3039238419A5061783632 @default.
- W3039238419 hasAuthorship W3039238419A5062046770 @default.
- W3039238419 hasAuthorship W3039238419A5066391845 @default.
- W3039238419 hasConcept C121332964 @default.
- W3039238419 hasConcept C2989005 @default.
- W3039238419 hasConcept C71924100 @default.
- W3039238419 hasConceptScore W3039238419C121332964 @default.
- W3039238419 hasConceptScore W3039238419C2989005 @default.
- W3039238419 hasConceptScore W3039238419C71924100 @default.
- W3039238419 hasLocation W30392384191 @default.
- W3039238419 hasOpenAccess W3039238419 @default.
- W3039238419 hasPrimaryLocation W30392384191 @default.
- W3039238419 hasRelatedWork W10388198 @default.
- W3039238419 hasRelatedWork W12607760 @default.
- W3039238419 hasRelatedWork W14956525 @default.
- W3039238419 hasRelatedWork W1830322 @default.
- W3039238419 hasRelatedWork W2185729 @default.
- W3039238419 hasRelatedWork W5009015 @default.
- W3039238419 hasRelatedWork W7019452 @default.
- W3039238419 hasRelatedWork W7633178 @default.
- W3039238419 hasRelatedWork W7721809 @default.
- W3039238419 hasRelatedWork W8118195 @default.
- W3039238419 isParatext "false" @default.
- W3039238419 isRetracted "false" @default.
- W3039238419 magId "3039238419" @default.
- W3039238419 workType "article" @default.